SlideShare a Scribd company logo
Safe Prescribing and
  Use of Opioids
        April 10-12, 2012
 Walt Disney World Swan Resort
Accepted Learning Objectives:
1. Analyze current professional education
programs on safe use of opioids and new
programs under development.
2. Explain a potentially transformative on-line
educational tool for health professionals that
enable them to train by interacting with “virtual
patients.”
3. Describe a Massachusetts program for training
physicians on safe opioid prescribing, and the
curriculum developed to teach residents
and faculty.
Disclosure Statement
•  Dr. Daniel P. Alford and Sarah Ball have  
   disclosed no relevant, real or apparent
   personal or professional financial
   relationships.
•  Benjamin Lok has disclosed that he has
   a relationship with Shadow Health, Inc.
Training Physicians
in the Safe and Effective
     Use of Opioids
                April 11, 2012
   Daniel P. Alford, MD, MPH, FACP, FASAM
          Associate Professor of Medicine
        Boston University School of Medicine
              Boston Medical Center
Agenda
  Training internal medicine residents and
   faculty
      National Institute on Drug Abuse (NIDA) sponsored
       teaching residents and faculty using Objective
       Structured Clinical Exams (OSCE)

  Statewide physician training
      Massachusetts Board of Registration in Medicine
       sponsored ½ day conferences and on-line training
Training
Residents
   and
 Faculty
Residents and Faculty
                             Educational Goals




Support	
  from	
  Na#onal	
  Ins#tute	
  on	
  Drug	
  Abuse	
  (N02	
  DA40252)	
  
Center	
  of	
  Excellence	
  for	
  Physician	
  Informa#on	
  
Two-Part Education Program
Didactic (1-hour PowerPoint lecture)
     Assess pain, function and opioid misuse risk
     Monitor for opioid benefits and risks
     Identify and manage opioid misuse
     Identify exit strategies for lack of benefit and/or increased risk


OSCE (Objective Structured Clinical Exams)
     Performance-based assessments of clinical skills using four 20-minute
      stations using standardized patients (SP) and immediate faculty
      observer feedback
OSCE Stations
Station 1:   Assess opioid misuse risk and discuss monitoring plan
             before starting opioids

Station 2:   Assess cause of aberrant opioid taking behavior and
             discuss modified treatment plan

Station 3:   Discuss opioid taper due to lack of benefit and
             apparent risk/harm

Station 4:   Perform a brief intervention for concurrent substance
             abuse in patient benefiting from opioids for chronic pain
OSCE Description
Time
(20 min)                           Activity
   2       Read station case & specific tasks (3 per case)

  10       SP interview

   1       Learner self-assess
           “What was the most challenging part of the interview?”

   1       SP assess learner
           “How did the interaction feel to you?”

   5       Faculty observer gives feedback to learner

   1       Move to next station
Station Tasks example
Resident Training
              Characteristics N=39

  31% reported no previous training in the use of
   opioids for managing chronic pain

  74% reported that their prior training was not
   enough

  23% reported starting patients on long-term
   opioids in the past three months
Resident Training Conclusions
  At 8 month follow up:
       Increased confidence in ability to communicate effectively
        with patients with chronic pain on long-term opioids
       Increased self-reported safe and effective opioid
        prescribing practices

  OSCEs are time consuming
       Can only train a small number of residents at one time
       Training faculty who precept residents using a “train the
        trainers” model may be more efficient way to train more
        residents
Faculty Training - Evaluation of OSCE
                                    N=19
                                                             Definitely
                                                               YES
In general the OSCE…                                          % (n)
Taught me something new                                       100 (19)
Was a valuable learning tool                                  100 (19)
Provided me with valuable feedback                            95 (18)

Evaluated my skills fairly                                    95 (18)
Provided a good cross-section of opioid prescribing issues    95 (18)
Stimulated me to learn more about opioid prescribing          84 (16)
Helped me identify my strengths and weakness                  84 (16)
Resembled real life clinical encounters                       84 (16)
Confidence

                                                                                                  *
In the outpatient setting, how confident are you…
Identifying risk factors for prescription opioid misuse

Discussing risks & benefits of long-term opioid therapy

Distinguishing inappropriate “drug seeking” from appropriate “pain relief
seeking” behaviors

Discussing results of abnormal urine drug tests

Discussing aberrant medication taking behaviors

Knowing when long-term opioid therapy is beneficial

Stopping opioid therapy due to lack of benefit or increased risk
                                                                            1=Not at all confident;
                                                                            5=Very confident
                                                                            5-pt scale (reliability 0.73)
                                                                                                            *p=.003
Practice
                                                                   *




In the outpatient setting, with chronic pain
patients, how often do you…
…assess pain using a numerical rating score?
….assess overall function?



                                               1=Never/Rarely; 5=Always
                                               5-pt scale (reliability 0.69)
                                                                             *p<.05
Practice
Non-significant changes in…

                                             Baseline 3-m f/u
 Frequency of….
     using controlled substance agreement     4.59     4.76
             conducting urine drug testing    4.12     4.18
                    conducting pill counts    1.91     1.71
                  1=Never/rarely, 5=Always
Confidence to Teach
Confidence to Teach
               *




                      * p=.001
Teaching

When precepting a resident caring for a patient
with chronic pain on long-term opioids, how
often do you teach them about…
identifying risk factors for opioid misuse

assessing the risks of long-term opioid therapy

assessing the benefits of long-term opioid therapy

monitoring for prescription opioid misuse of drugs

assessing the etiology for aberrant opioid taking behavior

assessing when to stop opioid therapy due to lack of benefit or
increased risk

                                                                  1=Never/Rarely; 5=Always
                                                                  5-pt scale (reliability 0.86)
Statewide
Physician
 Training
Statewide Physician Training
  November 2009 Executive Director, MA Board of Registration
  in Medicine (BORIM) approached BU CME office regarding
  increasing number of complaints regarding opioid
  prescribing and need to train physician in safe and effective
  opioid prescribing
Statewide Physician Training
  June 2010 first live ½ day training (5 CME credits)
      6/2010 – 3/2012 completed 7 trainings with 8th scheduled for 6/2012
      Funding SAMHSA or Pharma and modest registration fee ~$75
      Marketed by BORIM “Dear Colleague” email

  February 2011 www.opioidprescribing.com was launched (4 CME
   credits)
      Funding SAMHSA and MA BORIM with NO registration fee

  Concurrently…
      August 2010 MA enacted a law mandating physician education to be
      implemented by BORIM
      February 2012 BORIM requires 3 hours of opioid prescribing CME
Live ½ Day Trainings
  Didactics
     Scope of the problem
     Opioid efficacy, safety
     Prescription monitoring program
     Assessment & monitoring tools
     Communicating w/ patients,
      risk- benefit framework
     Exit strategies, addiction
      treatment

  Case discussion/video
   demonstrations

  Panel discussion (Board of
   Registration, Department of
   Public Health, DEA, State Police,
   AG office)
Live ½ Day Training Stats
                       6/2010-3/2012
  1,275 clinicians have attended 7 MA trainings
     92% physicians
        51% Primary Care (IM/FM)
        13% psych
        35% other
     8% NP/PA, RN, or Other

  Each training reached capacity w/in 48 hrs of
   publicity with waiting lists >100 per training
  March 2012 training sponsored by VT BORIM
  Talks underway with NH and RI
www.opioidprescribing.com	
  
On-line Training
  Module 1: Opioid efficacy & safety, assessment & monitoring tools

  Module 2: Communicating with patients & psychiatric co-
  morbidities

  Module 3: Case study

  Module 4: Three video vignettes
         Starting opioids, discussing monitoring
         Assessing aberrant opioid taking behavior, increasing monitoring
         Addressing lack of benefit and excessive risk, discontinuing opioid
Module 4: The Interview
Module 4: “Roundtable” Discussion
On-line Training Stats
                      2/2011-3/2012

  8109 users
      65% MD/DO
      17% Dentists
      12% NP/PA
      2% RN
      4% other


  14% of users from out-of-state
Overall Training Stats
             Live & On-line: 6/2010-3/2012
  Average participant rating 4.42 out of 5

  53% participants made a commitment to
   change practice with most common answers:
         Use pill counts, urine drug tests (27%)
         Better documentation (12%)
         Use patient agreements, informed consents (12%)
         Use prescription monitoring program (5%)
         Change in educating or communicating w/ pts (3%)

More Related Content

Similar to Daniel Alford

Clinical reaserch 112070804001
Clinical reaserch 112070804001Clinical reaserch 112070804001
Clinical reaserch 112070804001Patel Parth
 
Clinical reaserch 112070804001
Clinical reaserch 112070804001Clinical reaserch 112070804001
Clinical reaserch 112070804001
Patel Parth
 
Evidence Based Medicine - Overview
Evidence Based Medicine - OverviewEvidence Based Medicine - Overview
Evidence Based Medicine - Overview
DocIbrahimAbdelmonaem
 
Barriers to opioid monitoring in primary care
Barriers to opioid monitoring in primary careBarriers to opioid monitoring in primary care
Barriers to opioid monitoring in primary care
Group Health Cooperative
 
EBM for Haematology - Workshop 5
EBM for Haematology - Workshop 5EBM for Haematology - Workshop 5
EBM for Haematology - Workshop 5Robin Featherstone
 
Presentation_Thesis defense _Thi Ha VO. 16.12.2015
Presentation_Thesis defense _Thi Ha VO. 16.12.2015Presentation_Thesis defense _Thi Ha VO. 16.12.2015
Presentation_Thesis defense _Thi Ha VO. 16.12.2015
HA VO THI
 
Fca30651 b07c-43be-a28a-80e171e7cca4
Fca30651 b07c-43be-a28a-80e171e7cca4Fca30651 b07c-43be-a28a-80e171e7cca4
Fca30651 b07c-43be-a28a-80e171e7cca4Vicky Gerardi
 
Guidelines for Teaching Evidence-Based Medicine in Your Practice
Guidelines for Teaching Evidence-Based Medicine in Your PracticeGuidelines for Teaching Evidence-Based Medicine in Your Practice
Guidelines for Teaching Evidence-Based Medicine in Your Practice
TucsonMedicalCenter
 
Evaluating A Guideline Panic Disorder
Evaluating A Guideline Panic DisorderEvaluating A Guideline Panic Disorder
Evaluating A Guideline Panic Disorder
subaspradhan
 
Studying a study 5ta edición
Studying a study 5ta ediciónStudying a study 5ta edición
Studying a study 5ta ediciónGẽrman Diãz
 
Outcomes: ASH 2010 (Multiple Myeloma)
Outcomes: ASH 2010 (Multiple Myeloma)Outcomes: ASH 2010 (Multiple Myeloma)
Outcomes: ASH 2010 (Multiple Myeloma)
Curatio CME Institute
 
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...PROIDDBahiana
 
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...PROIDDBahiana
 
Ebm
EbmEbm
How to form a clinical question. cincinnati childrens
How to form a clinical question. cincinnati childrensHow to form a clinical question. cincinnati childrens
How to form a clinical question. cincinnati childrensCatherineMiller2
 
One Minute Preceptor .ppt
One Minute Preceptor .pptOne Minute Preceptor .ppt
One Minute Preceptor .ppt
DhwaniDesai18
 
Introduction to Clinical trial
Introduction to Clinical trial Introduction to Clinical trial
Introduction to Clinical trial
rx_sonali
 
Evidence based practice
Evidence  based  practiceEvidence  based  practice
Evidence based practice
kuldeep amin
 

Similar to Daniel Alford (20)

Clinical reaserch 112070804001
Clinical reaserch 112070804001Clinical reaserch 112070804001
Clinical reaserch 112070804001
 
Clinical reaserch 112070804001
Clinical reaserch 112070804001Clinical reaserch 112070804001
Clinical reaserch 112070804001
 
Dr.little mesa 3
Dr.little mesa 3Dr.little mesa 3
Dr.little mesa 3
 
Evidence Based Medicine - Overview
Evidence Based Medicine - OverviewEvidence Based Medicine - Overview
Evidence Based Medicine - Overview
 
Barriers to opioid monitoring in primary care
Barriers to opioid monitoring in primary careBarriers to opioid monitoring in primary care
Barriers to opioid monitoring in primary care
 
EBM for Haematology - Workshop 5
EBM for Haematology - Workshop 5EBM for Haematology - Workshop 5
EBM for Haematology - Workshop 5
 
Presentation_Thesis defense _Thi Ha VO. 16.12.2015
Presentation_Thesis defense _Thi Ha VO. 16.12.2015Presentation_Thesis defense _Thi Ha VO. 16.12.2015
Presentation_Thesis defense _Thi Ha VO. 16.12.2015
 
Fca30651 b07c-43be-a28a-80e171e7cca4
Fca30651 b07c-43be-a28a-80e171e7cca4Fca30651 b07c-43be-a28a-80e171e7cca4
Fca30651 b07c-43be-a28a-80e171e7cca4
 
Guidelines for Teaching Evidence-Based Medicine in Your Practice
Guidelines for Teaching Evidence-Based Medicine in Your PracticeGuidelines for Teaching Evidence-Based Medicine in Your Practice
Guidelines for Teaching Evidence-Based Medicine in Your Practice
 
Uwm 6 aug 2010
Uwm 6 aug 2010Uwm 6 aug 2010
Uwm 6 aug 2010
 
Evaluating A Guideline Panic Disorder
Evaluating A Guideline Panic DisorderEvaluating A Guideline Panic Disorder
Evaluating A Guideline Panic Disorder
 
Studying a study 5ta edición
Studying a study 5ta ediciónStudying a study 5ta edición
Studying a study 5ta edición
 
Outcomes: ASH 2010 (Multiple Myeloma)
Outcomes: ASH 2010 (Multiple Myeloma)Outcomes: ASH 2010 (Multiple Myeloma)
Outcomes: ASH 2010 (Multiple Myeloma)
 
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...
 
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...
Ability of-primary-care-physician’s-to-break-bad-news-amiel-ungar-alperin-bah...
 
Ebm
EbmEbm
Ebm
 
How to form a clinical question. cincinnati childrens
How to form a clinical question. cincinnati childrensHow to form a clinical question. cincinnati childrens
How to form a clinical question. cincinnati childrens
 
One Minute Preceptor .ppt
One Minute Preceptor .pptOne Minute Preceptor .ppt
One Minute Preceptor .ppt
 
Introduction to Clinical trial
Introduction to Clinical trial Introduction to Clinical trial
Introduction to Clinical trial
 
Evidence based practice
Evidence  based  practiceEvidence  based  practice
Evidence based practice
 

More from OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
OPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
OPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
OPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
OPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
OPUNITE
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
OPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
OPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
OPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
OPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
OPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
OPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
OPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
OPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
OPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
OPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
OPUNITE
 

More from OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 

Recently uploaded

263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptxTemporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
Dr. Rabia Inam Gandapore
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 

Recently uploaded (20)

263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptxTemporomandibular Joint By RABIA INAM GANDAPORE.pptx
Temporomandibular Joint By RABIA INAM GANDAPORE.pptx
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 

Daniel Alford

  • 1. Safe Prescribing and Use of Opioids April 10-12, 2012 Walt Disney World Swan Resort
  • 2. Accepted Learning Objectives: 1. Analyze current professional education programs on safe use of opioids and new programs under development. 2. Explain a potentially transformative on-line educational tool for health professionals that enable them to train by interacting with “virtual patients.” 3. Describe a Massachusetts program for training physicians on safe opioid prescribing, and the curriculum developed to teach residents and faculty.
  • 3. Disclosure Statement •  Dr. Daniel P. Alford and Sarah Ball have   disclosed no relevant, real or apparent personal or professional financial relationships. •  Benjamin Lok has disclosed that he has a relationship with Shadow Health, Inc.
  • 4. Training Physicians in the Safe and Effective Use of Opioids April 11, 2012 Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Boston University School of Medicine Boston Medical Center
  • 5. Agenda   Training internal medicine residents and faculty   National Institute on Drug Abuse (NIDA) sponsored teaching residents and faculty using Objective Structured Clinical Exams (OSCE)   Statewide physician training   Massachusetts Board of Registration in Medicine sponsored ½ day conferences and on-line training
  • 6. Training Residents and Faculty
  • 7. Residents and Faculty Educational Goals Support  from  Na#onal  Ins#tute  on  Drug  Abuse  (N02  DA40252)   Center  of  Excellence  for  Physician  Informa#on  
  • 8. Two-Part Education Program Didactic (1-hour PowerPoint lecture)   Assess pain, function and opioid misuse risk   Monitor for opioid benefits and risks   Identify and manage opioid misuse   Identify exit strategies for lack of benefit and/or increased risk OSCE (Objective Structured Clinical Exams)   Performance-based assessments of clinical skills using four 20-minute stations using standardized patients (SP) and immediate faculty observer feedback
  • 9. OSCE Stations Station 1: Assess opioid misuse risk and discuss monitoring plan before starting opioids Station 2: Assess cause of aberrant opioid taking behavior and discuss modified treatment plan Station 3: Discuss opioid taper due to lack of benefit and apparent risk/harm Station 4: Perform a brief intervention for concurrent substance abuse in patient benefiting from opioids for chronic pain
  • 10. OSCE Description Time (20 min) Activity 2 Read station case & specific tasks (3 per case) 10 SP interview 1 Learner self-assess “What was the most challenging part of the interview?” 1 SP assess learner “How did the interaction feel to you?” 5 Faculty observer gives feedback to learner 1 Move to next station
  • 12. Resident Training Characteristics N=39   31% reported no previous training in the use of opioids for managing chronic pain   74% reported that their prior training was not enough   23% reported starting patients on long-term opioids in the past three months
  • 13. Resident Training Conclusions   At 8 month follow up:   Increased confidence in ability to communicate effectively with patients with chronic pain on long-term opioids   Increased self-reported safe and effective opioid prescribing practices   OSCEs are time consuming   Can only train a small number of residents at one time   Training faculty who precept residents using a “train the trainers” model may be more efficient way to train more residents
  • 14. Faculty Training - Evaluation of OSCE N=19 Definitely YES In general the OSCE… % (n) Taught me something new 100 (19) Was a valuable learning tool 100 (19) Provided me with valuable feedback 95 (18) Evaluated my skills fairly 95 (18) Provided a good cross-section of opioid prescribing issues 95 (18) Stimulated me to learn more about opioid prescribing 84 (16) Helped me identify my strengths and weakness 84 (16) Resembled real life clinical encounters 84 (16)
  • 15. Confidence * In the outpatient setting, how confident are you… Identifying risk factors for prescription opioid misuse Discussing risks & benefits of long-term opioid therapy Distinguishing inappropriate “drug seeking” from appropriate “pain relief seeking” behaviors Discussing results of abnormal urine drug tests Discussing aberrant medication taking behaviors Knowing when long-term opioid therapy is beneficial Stopping opioid therapy due to lack of benefit or increased risk 1=Not at all confident; 5=Very confident 5-pt scale (reliability 0.73) *p=.003
  • 16. Practice * In the outpatient setting, with chronic pain patients, how often do you… …assess pain using a numerical rating score? ….assess overall function? 1=Never/Rarely; 5=Always 5-pt scale (reliability 0.69) *p<.05
  • 17. Practice Non-significant changes in… Baseline 3-m f/u Frequency of…. using controlled substance agreement 4.59 4.76 conducting urine drug testing 4.12 4.18 conducting pill counts 1.91 1.71 1=Never/rarely, 5=Always
  • 19. Confidence to Teach * * p=.001
  • 20. Teaching When precepting a resident caring for a patient with chronic pain on long-term opioids, how often do you teach them about… identifying risk factors for opioid misuse assessing the risks of long-term opioid therapy assessing the benefits of long-term opioid therapy monitoring for prescription opioid misuse of drugs assessing the etiology for aberrant opioid taking behavior assessing when to stop opioid therapy due to lack of benefit or increased risk 1=Never/Rarely; 5=Always 5-pt scale (reliability 0.86)
  • 22. Statewide Physician Training   November 2009 Executive Director, MA Board of Registration in Medicine (BORIM) approached BU CME office regarding increasing number of complaints regarding opioid prescribing and need to train physician in safe and effective opioid prescribing
  • 23. Statewide Physician Training   June 2010 first live ½ day training (5 CME credits)   6/2010 – 3/2012 completed 7 trainings with 8th scheduled for 6/2012   Funding SAMHSA or Pharma and modest registration fee ~$75   Marketed by BORIM “Dear Colleague” email   February 2011 www.opioidprescribing.com was launched (4 CME credits)   Funding SAMHSA and MA BORIM with NO registration fee   Concurrently…   August 2010 MA enacted a law mandating physician education to be implemented by BORIM   February 2012 BORIM requires 3 hours of opioid prescribing CME
  • 24. Live ½ Day Trainings   Didactics   Scope of the problem   Opioid efficacy, safety   Prescription monitoring program   Assessment & monitoring tools   Communicating w/ patients, risk- benefit framework   Exit strategies, addiction treatment   Case discussion/video demonstrations   Panel discussion (Board of Registration, Department of Public Health, DEA, State Police, AG office)
  • 25. Live ½ Day Training Stats 6/2010-3/2012   1,275 clinicians have attended 7 MA trainings   92% physicians   51% Primary Care (IM/FM)   13% psych   35% other   8% NP/PA, RN, or Other   Each training reached capacity w/in 48 hrs of publicity with waiting lists >100 per training   March 2012 training sponsored by VT BORIM   Talks underway with NH and RI
  • 27. On-line Training   Module 1: Opioid efficacy & safety, assessment & monitoring tools   Module 2: Communicating with patients & psychiatric co- morbidities   Module 3: Case study   Module 4: Three video vignettes   Starting opioids, discussing monitoring   Assessing aberrant opioid taking behavior, increasing monitoring   Addressing lack of benefit and excessive risk, discontinuing opioid
  • 28.
  • 29. Module 4: The Interview
  • 31. On-line Training Stats 2/2011-3/2012   8109 users   65% MD/DO   17% Dentists   12% NP/PA   2% RN   4% other   14% of users from out-of-state
  • 32. Overall Training Stats Live & On-line: 6/2010-3/2012   Average participant rating 4.42 out of 5   53% participants made a commitment to change practice with most common answers:   Use pill counts, urine drug tests (27%)   Better documentation (12%)   Use patient agreements, informed consents (12%)   Use prescription monitoring program (5%)   Change in educating or communicating w/ pts (3%)